Left atrial appendage-occluding devices for stroke prevention in patients with nonvalvular atrial fibrillation

Expert Review of Medical Devices

Volumn 6, Issue 6, 2009, Pages 611-620

  Yan, Bryan P ^a,b   Kiernan, Thomas J ^c   Gonzales Cruz, Ignacio ^d   Lam, Yat Yin ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b MONASH UNIVERSITY   (Australia)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

Author keywords

Atrial fibrillation; Left atrial appendage; Oral anticoagulation; Stroke

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; NITINOL; POLYETHYLENE; WARFARIN;

ARTIFICIAL EMBOLISM; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; EQUIPMENT DESIGN; HEART ATRIUM APPENDAGE; HEART ATRIUM FIBRILLATION; HEART CATHETERIZATION; HEART LEFT ATRIUM; HEART SURGERY; HUMAN; IMPLANT; PATIENT SELECTION; PROGNOSIS; REVIEW; RISK REDUCTION; THROMBOEMBOLISM;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ATRIAL APPENDAGE; ATRIAL FIBRILLATION; CATHETER ABLATION; CATHETERIZATION; CLINICAL TRIALS AS TOPIC; ECHOCARDIOGRAPHY; EQUIPMENT AND SUPPLIES; EQUIPMENT DESIGN; HEART ATRIA; HUMANS; PROSTHESES AND IMPLANTS; RISK FACTORS; STROKE; THROMBOEMBOLISM;

EID: 73549089688     PISSN: 17434440     EISSN: 17452422     Source Type: Journal    
DOI: 10.1586/erd.09.45     Document Type: Review

References (40)

1. Hart RG, Halperin JL. Atrial fibrillation and thromboembolism: a decade of progress in stroke prevention. Ann. Intern. Med. 131(9), 688-695 (1999).
2. Feinberg WM, Blackshear JL, Laupacis A, Kronmal R, Hart RG. Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications. Arch. Intern. Med. 155(5), 469-473 (1995).
3. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch. Intern. Med. 154(13), 1449-1457 (1994).
4. Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA 285(22), 2864-2870 (2001).
5. Fuster V, Ryden LE, Cannom DS et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation - executive summary: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation). J. Am. Coll. Cardiol. 48(4), 854-906 (2006).
6. Onalan O, Lashevsky I, Hamad A, Crystal E. Nonpharmacologic stroke prevention in atrial fibrillation. Expert Rev. Cardiovasc. Ther. 3(4), 619-633 (2005).
7. Ferro D, Loffredo L, Polimeni L, Violi F. Underuse of oral anticoagulants in patients with nonvalvular atrial fibrillation in Italy. Intern. Emerg. Med. 2(1), 24-28 (2007).
8. Stafford RS, Singer DE. Recent national patterns of warfarin use in atrial fibrillation. Circulation 97(13), 1231-1233 (1998).
9. Amouyel P, Mismetti P, Langkilde LK, Jasso-Mosqueda G, Nelander K, Lamarque H. INR variability in atrial fibrillation: a risk model for cerebrovascular events. Eur. J. Intern. Med. 20(1), 63-69 (2009).
10. Fountain RB, Holmes DR, Chandrasekaran K et al. The PROTECT AF (WATCHMAN Left Atrial Appendage System for Embolic Protection in Patients with Atrial Fibrillation) trial. Am. Heart J. 151(5), 956-961 (2006).
11. Blackshear JL, Odell JA. Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation. Ann. Thorac. Surg. 61(2), 755-759 (1996).
12. Bonow RO, Carabello BA, Chatterjee K et al. 2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation 118(15), E523-E661 (2008).
13. Bando K, Kobayashi J, Hirata M et al. Early and late stroke after mitral valve replacement with a mechanical prosthesis: risk factor analysis of a 24-year experience. J. Thorac. Cardiovasc. Surg. 126(2), 358-364 (2003).
14. Lerakis S, Synetos A. Left atrial appendage exclusion system for stroke prevention in atrial fibrillation: a percutaneous device delivery approach. Minerva Cardioangiol 56(6), 667-670 (2008).
15. El-Chami MF, Hoffman M, Lerakis S. Sealing the left atrial appendage: ready for prime time? Am. J. Med. Sci. 333(5), 285-289 (2007).
16. Ernst G, Stollberger C, Abzieher F et al. Morphology of the left atrial appendage. Anat. Rec. 242(4), 553-561 (1995).
17. Tabata T, Oki T, Yamada H et al. Role of left atrial appendage in left atrial reservoir function as evaluated by left atrial appendage clamping during cardiac surgery. Am. J. Cardiol. 81(3), 327-332 (1998).
18. Veinot JP, Harrity PJ, Gentile F et al. Anatomy of the normal left atrial appendage: a quantitative study of age-related changes in 500 autopsy hearts: implications for echocardiographic examination. Circulation 96(9), 3112-3115(1997).
19. Kamalesh M, Copeland TB, Sawada S. Effect of inotropic stimulation on left atrial appendage function in atrial myopathy of chronic atrial fibrillation. Echocardiography 17(4), 313-318 (2000).
20. Garcia-Fernandez MA, Perez-David E, Quiles J et al. Role of left atrial appendage obliteration in stroke reduction in patients with mitral valve prosthesis: a transesophageal echocardiographic study. J. Am. Coll. Cardiol. 42(7), 1253-1258 (2003).
21. Katz ES, Tsiamtsiouris T, Applebaum RM, Schwartzbard A, Tunick PA, Kronzon I. Surgical left atrial appendage ligation is frequently incomplete: a transesophageal echocardiograhic study. J. Am. Coll. Cardiol. 36(2), 468-471 (2000).
22. Johnson WD, Ganjoo AK, Stone CD, Srivyas RC, Howard M. The left atrial appendage: our most lethal human attachment! Surgical implications. Eur. J. Cardiothorac. Surg. 17(6), 718-722 (2000).
23. Kiaii B, McClure RS, Skanes AC et al. Robotic-assisted left atrial ligation for stroke reduction in chronic atrial fibrillation: a case report. Heart Surg. Forum 9(1), E533-E535; discussion E535 (2006).
24. Gillinov AM, Pettersson G, Cosgrove DM. Stapled excision of the left atrial appendage. J. Thorac. Cardiovasc. Surg. 129(3), 679-680 (2005).
25. Healey JS, Crystal E, Lamy A et al. Left Atrial Appendage Occlusion Study (LAAOS): results of a randomized controlled pilot study of left atrial appendage occlusion during coronary bypass surgery in patients at risk for stroke. Am. Heart J. 150(2), 288-293 (2005).
26. Blackshear JL, Johnson WD, Odell JA et al. Thoracoscopic extracardiac obliteration of the left atrial appendage for stroke risk reduction in atrial fibrillation. J. Am. Coll. Cardiol. 42(7), 1249-1252 (2003).
27. Groh MA, Binns OA, Burton HG 3rd, Champsaur GL, Ely SW, Johnson AM. Epicardial ultrasonic ablation of atrial fibrillation during concomitant cardiac surgery is a valid option in patients with ischemic heart disease. Circulation 118(14 Suppl.), S78-S82 (2008).
28. Knaut M, Brose S, Tugtekin SM, Kappert U, Jung F, Matschke K. Microwave ablation of permanent atrial fibrillation during isolated bypass grafting and isolated mitral valve surgery. Heart Surg. Forum 10(2), E153-E157 (2007).
29. Sievert H, Lesh MD, Trepels T et al. Percutaneous left atrial appendage transcatheter occlusion to prevent stroke in high-risk patients with atrial fibrillation: early clinical experience. Circulation 105(16), 1887-1889 (2002).
30. Nakai T, Lesh MD, Gerstenfeld EP, Virmani R, Jones R, Lee RJ. Percutaneous left atrial appendage occlusion (PLAATO) for preventing cardioembolism: first experience in canine model. Circulation 105(18), 2217-2222 (2002).
31. Ostermayer SH, Reisman M, Kramer PH et al. Percutaneous left atrial appendage transcatheter occlusion (PLAATO system) to prevent stroke in high-risk patients with non-rheumatic atrial fibrillation: results from the international multi-center feasibility trials. J. Am. Coll. Cardiol. 46(1), 9-14 (2005).
32. Bayard YL, Ostermayer SH, Sievert H. Transcatheter occlusion of the left atrial appendage for stroke prevention. Expert Rev. Cardiovasc. Ther. 3(6), 1003-1008 (2005).
33. El-Chami MF, Grow P, Eilen D, Lerakis S, Block PC. Clinical outcomes three years after PLAATO implantation. Catheter Cardiovasc. Interv. 69(5), 704-707 (2007).
34. Ussia GP, Mule M, Cammalleri V et al. Percutaneous closure of left atrial appendage to prevent embolic events in high-risk patients with chronic atrial fibrillation. Catheter Cardiovasc. Interv. 74(2), 217-222(2009).
35. Sick PB, Schuler G, Hauptmann KE et al. Initial worldwide experience with the WATCHMAN left atrial appendage system for stroke prevention in atrial fibrillation. J. Am. Coll. Cardiol. 49(13), 1490-1495 (2007).
36. Zhao L, Woodworth G. Bayesian decision sequential analysis with survival endpoint in Phase II clinical trials. Stat. Med. 28(9), 1339-1352 (2009).
37. Meier B, Palacios I, Windecker S et al. Transcatheter left atrial appendage occlusion with Amplatzer devices to obviate anticoagulation in patients with atrial fibrillation. Catheter Cardiovasc. Interv. 60(3), 417-422 (2003).
38. Friedman PA, Asirvatham SJ, Dalegrave C et al. Percutaneous epicardial left atrial appendage closure: preliminary results of an electrogram guided approach. J. Cardiovasc. Electrophysiol. 20(8), 908-915 (2009).
39. Jorgensen J, Palmer S, Kalogeropoulos A et al. Implantation of left atrial appendage occlusion devices and complex appendage anatomy: the importance of transesophageal echocardiography. Echocardiography 24(2), 159-161 (2007).
40. Ho IC, Neuzil P, Mraz T et al. Use of intracardiac echocardiography to guide implantation of a left atrial appendage occlusion device (PLAATO). Heart Rhythm 4(5), 567-571 (2007).